S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
3 Value Stocks Too Small For Buffett’s Portfolio
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
3 Value Stocks Too Small For Buffett’s Portfolio
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
3 Value Stocks Too Small For Buffett’s Portfolio
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
3 Value Stocks Too Small For Buffett’s Portfolio
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NASDAQ:MEDS

TRxADE HEALTH (MEDS) Stock Price, News & Analysis

$10.24
+0.69 (+7.23%)
(As of 05:21 PM ET)
Today's Range
$8.53
$10.74
50-Day Range
$4.11
$33.90
52-Week Range
$3.69
$44.56
Volume
113,108 shs
Average Volume
443,030 shs
Market Capitalization
$12.39 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
MEDS stock logo

About TRxADE HEALTH Stock (NASDAQ:MEDS)

TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which offers price transparency, purchasing capabilities, and other value-added services; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Lutz, Florida.

MEDS Stock Price History

MEDS Stock News Headlines

SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
TRxADE Health, Inc. Announces Special Cash Dividend
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
GCT, VHC and IPWR among mid-day movers
Why Is Trxade Health (MEDS) Stock Up 230% Today?
10 Medications Linked to Dementia
Trxade health, Inc files its 3Q 10Q
Medications for Essential Tremor
See More Headlines
Receive MEDS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TRxADE HEALTH and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
1/16/2024
Dividend Payable
3/22/2024
Ex-Dividend for 3/22 Dividend
3/25/2024
Today
3/28/2024
Next Earnings (Estimated)
5/13/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drugs, proprietaries, & sundries
Sub-Industry
N/A
Current Symbol
NASDAQ:MEDS
Employees
33
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$0.00
High Stock Price Target
$0.00
Low Stock Price Target
$10,000,000.00
Potential Upside/Downside
+174.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
0 Analysts

Profitability

Net Income
$-3,470,000.00
Pretax Margin
-43.63%

Debt

Sales & Book Value

Annual Sales
$11.45 million
Book Value
$0.55 per share

Miscellaneous

Free Float
622,000
Market Cap
$11.56 million
Optionable
Not Optionable
Beta
1.90
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives


MEDS Stock Analysis - Frequently Asked Questions

How have MEDS shares performed in 2024?

TRxADE HEALTH's stock was trading at $5.20 at the beginning of the year. Since then, MEDS stock has increased by 100.0% and is now trading at $10.40.
View the best growth stocks for 2024 here
.

Are investors shorting TRxADE HEALTH?

TRxADE HEALTH saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 56,000 shares, an increase of 80.6% from the February 29th total of 31,000 shares. Based on an average trading volume of 414,100 shares, the short-interest ratio is presently 0.1 days. Approximately 6.6% of the shares of the company are sold short.
View TRxADE HEALTH's Short Interest
.

When is TRxADE HEALTH's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, April 1st 2024.
View our MEDS earnings forecast
.

How were TRxADE HEALTH's earnings last quarter?

TRxADE HEALTH, Inc. (NASDAQ:MEDS) released its quarterly earnings data on Tuesday, January, 16th. The company reported ($0.07) earnings per share for the quarter. The firm had revenue of $2.06 million for the quarter. TRxADE HEALTH had a negative net margin of 78.18% and a negative trailing twelve-month return on equity of 69.22%.

How often does TRxADE HEALTH pay dividends? What is the dividend yield for TRxADE HEALTH?

TRxADE HEALTH declared a dividend on Wednesday, February 28th. Shareholders of record on Monday, March 18th will be paid a dividend of $8.00 per share on Friday, March 22nd. The ex-dividend date is Monday, March 25th.
Read our dividend analysis for MEDS
.

When did TRxADE HEALTH's stock split?

TRxADE HEALTH's stock reverse split on the morning of Thursday, June 22nd 2023. The 1-15 reverse split was announced on Thursday, June 22nd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

What other stocks do shareholders of TRxADE HEALTH own?

Based on aggregate information from My MarketBeat watchlists, some companies that other TRxADE HEALTH investors own include Advanced Micro Devices (AMD), Biocept (BIOC), iBio (IBIO), Ollie's Bargain Outlet (OLLI), OPKO Health (OPK), Alto Ingredients (PEIX), Tiziana Life Sciences (TLSA) and Trevena (TRVN).

How do I buy shares of TRxADE HEALTH?

Shares of MEDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:MEDS) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners